Carmustine in Treating Patients With Recurrent Malignant Glioma

Clinical trial NCT00004028 · COMPLETED

Trial details

NCT number: NCT00004028
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 1996-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.